Sort
64,565 grants matching “drug discovery”
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
$688,498Calvin J Kuo · Stanford University · R01 · FY2018 · DK
Functional consequences of cancer mutations
$688,494Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Adenine Base Edited Correction of Cystic Fibrosis Airways
$688,492Patrick L Sinn · University Of Iowa · R01 · FY2025 · HL
Software for Accurate Ligand-Protein Affinities
$688,481Michael J Potter · Verachem, Llc · R44 · FY2006 · GM
Cancer Center Administration
$688,399Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Contributions of aberrant synaptic protein monoaminylation to opiate use disorder
$688,381Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA
A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum
$688,366Kathleen Joyce Millen · Seattle Children'S Hospital · R01 · FY2025 · NS
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug
$688,344Kojo Mensa-Wilmot · Kennesaw State University · R01 · FY2021 · AI
Perijunctional myosin light chain kinase recruitment: A novel, non-enzymatic target for therapeutic intestinal barrier restoration
$688,227Jerrold R. Turner · Brigham And Women'S Hospital · R01 · FY2019 · DK
Perijunctional myosin light chain kinase recruitment: A novel, non-enzymatic target for therapeutic intestinal barrier restoration
$688,227Jerrold R. Turner · Brigham And Women'S Hospital · R01 · FY2022 · DK
Perijunctional myosin light chain kinase recruitment: A novel, non-enzymatic target for therapeutic intestinal barrier restoration
$688,227Jerrold R. Turner · Brigham And Women'S Hospital · R01 · FY2021 · DK
Perijunctional myosin light chain kinase recruitment: A novel, non-enzymatic target for therapeutic intestinal barrier restoration
$688,227Jerrold R. Turner · Brigham And Women'S Hospital · R01 · FY2020 · DK
Expanding the Chemical Diversity of Therapeutic Oligonucleotides
$688,196Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · NS
Expanding the Chemical Diversity of Therapeutic Oligonucleotides
$688,196Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · NS
Project 2 Bacterial determinants of host adaptation and evolutionary success
$688,193Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · AI
Center for Humanized Mice
$688,191Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2014 · OD
Inexpensive Interactive Molecular Modeling Software
$688,147Verachem, Llc · R42 · FY2004 · GM
L1 retrotransposon-based mutagenesis for rat models of human diseases
$688,143Eric M Ostertag · Transposagen Biopharmaceuticals, Inc. · R44 · FY2007 · RR
MECHANISM-BASED DRUG SELECTION AND DESIGN: NUCLEOTIDE SA
$688,098Oregon Health And Science University · R01 · FY2000 · AI
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$688,010Ashok B. Kulkarni · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
ECOLOGICALLY GUIDED BIOPROSPECTING IN PANAMA
$688,000Smithsonian Institution · U01 · FY2001 · TW
Alzheimer Disease Genetic Architecture in African Americans
$687,987Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2023 · AG
Alzheimer Disease Genetic Architecture in African Americans
$687,987Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2024 · AG
CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)
$687,904Nancy J. Cox · University Of Chicago · U01 · FY2010 · GM
Cannabinergic Medications for Methamphetamine Addiction
$687,900Alexandros Makriyannis · Northeastern University · R37 · FY2013 · DA